Intellia Therapeutics, Inc. (NTLA) vs Pacific Biosciences of Californ (PACB)
Detailed comparison between Intellia Therapeutics, Inc., Pacific Biosciences of Californ.Total Return (%)
Intellia Therapeutics, Inc. (NTLA)Pacific Biosciences of Californ (PACB)
Which stock do you think will perform better?
Intellia Therapeutics, Inc.
NTLA
Pacific Biosciences of Californ
PACB
| Metric | Intellia Therapeutics, Inc. (NTLA) | Pacific Biosciences of Californ (PACB) |
|---|---|---|
| Current Price | $12.06 | $1.37 |
| Change | 0.23 (1.94%) | -0.02 (-1.44%) |
| Market Cap | $1.25B | $0.41B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -2.19 | -2.01 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $28.18 | $2.72 |
| 52-Week Low | $5.90 | $0.85 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.23 | $-2.74 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NTLA | 31.09% | 21.33% | -52.39% | -45.75% | -45.43% | -45.43% |
| PACB | 7.87% | -19.41% | -23.89% | -67.54% | -73.14% | -73.14% |